Detalhe da pesquisa
1.
Phase 1b study of enzalutamide plus CC-115, a dual mTORC1/2 and DNA-PK inhibitor, in men with metastatic castration-resistant prostate cancer (mCRPC).
Br J Cancer
; 130(1): 53-62, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37980367
2.
A phase II study of the dual mTOR inhibitor MLN0128 in patients with metastatic castration resistant prostate cancer.
Invest New Drugs
; 36(3): 458-467, 2018 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29508246
3.
A Proposal for the Comprehensive Care of Men on Androgen Deprivation Therapy: Recommendations From the Multidisciplinary Prostate Cancer 360 Working Group.
Urol Pract
; 11(1): 18-29, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37917591
4.
Randomized Phase II Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in the Treatment of Metastatic Castration-Resistant Prostate Cancer.
J Clin Oncol
; 41(32): 5015-5024, 2023 Nov 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37582240
6.
Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer.
Clin Cancer Res
; 13(6): 1775-82, 2007 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-17363532
7.
Rapid androgen cycling as treatment for patients with prostate cancer.
Clin Cancer Res
; 12(24): 7414-21, 2006 Dec 15.
Artigo
Inglês
| MEDLINE | ID: mdl-17189414
8.
Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic prostate cancer.
J Clin Oncol
; 23(7): 1439-46, 2005 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-15735119
9.
Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer.
J Clin Oncol
; 23(17): 3923-31, 2005 Jun 10.
Artigo
Inglês
| MEDLINE | ID: mdl-15897550
10.
Potential role of histone deacetylase inhibitors in mesothelioma: clinical experience with suberoylanilide hydroxamic acid.
Clin Lung Cancer
; 7(4): 257-61, 2006 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-16512979
11.
Pilot trial of unlabeled and indium-111-labeled anti-prostate-specific membrane antigen antibody J591 for castrate metastatic prostate cancer.
Clin Cancer Res
; 11(20): 7454-61, 2005 Oct 15.
Artigo
Inglês
| MEDLINE | ID: mdl-16243819
12.
Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously.
Clin Cancer Res
; 9(10 Pt 1): 3578-88, 2003 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-14506144
13.
Nursing management of patients with castration-resistant prostate cancer undergoing radium-223 dichloride treatment.
Clin J Oncol Nurs
; 19(2): E31-5, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25840395
14.
A phase I trial of docetaxel and pulse-dose 17-allylamino-17-demethoxygeldanamycin in adult patients with solid tumors.
Cancer Chemother Pharmacol
; 69(4): 1089-97, 2012 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-22124669
15.
Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate cancer.
Eur Urol
; 56(2): 237-44, 2009 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-19375217
16.
Phase I study of samarium-153 lexidronam with docetaxel in castration-resistant metastatic prostate cancer.
J Clin Oncol
; 27(15): 2436-42, 2009 May 20.
Artigo
Inglês
| MEDLINE | ID: mdl-19364960
17.
Phase II trial of docetaxel with rapid androgen cycling for progressive noncastrate prostate cancer.
J Clin Oncol
; 26(18): 2959-65, 2008 Jun 20.
Artigo
Inglês
| MEDLINE | ID: mdl-18565882
18.
Estimating survival benefit in castrate metastatic prostate cancer: decision making in proceeding to a definitive phase III trial.
Urology
; 61(1): 142-4, 2003 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-12559285
19.
Clinical experience with intravenous estramustine phosphate, paclitaxel, and carboplatin in patients with castrate, metastatic prostate adenocarcinoma.
Cancer
; 98(9): 1842-8, 2003 Nov 01.
Artigo
Inglês
| MEDLINE | ID: mdl-14584065
20.
High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinoma.
Cancer
; 100(9): 1868-75, 2004 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-15112267